№ lp_1_2_49253
File format: docx
Character count: 7540
File size: 51 KB
REACH BC is an online platform designed to connect residents of British Columbia with health research opportunities by offering volunteer matching for research studies and providing necessary documentation for the REB application process.
Year:
2023
Region / City:
British Columbia
Topic:
Health Research, Recruitment
Document Type:
Guide
Organization / Institution:
Michael Smith Health Research BC
Author:
Not specified
Target Audience:
Researchers, Ethics Boards, Health Researchers
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Changes:
January 2023
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2003
Region / City:
Mount Sinai Hospital
Subject:
Clinical Research
Document Type:
Guideline
Organization / Institution:
Mount Sinai Hospital REB
Author:
REB Chair
Target Audience:
Clinical Investigators, Research Staff
Effective Period:
Ongoing
Approval Date:
November 6, 2003
Revision Date:
July 8, 2015
Year:
2024
Region / City:
Ottawa
Theme:
Research ethics, health research
Document Type:
Job posting
Institution:
CHEO Research Institute
Author:
N/A
Target audience:
Job seekers, health research professionals
Period of validity:
N/A
Approval date:
N/A
Date of amendments:
N/A
Year:
2023
Region / city:
Toronto, Canada
Subject:
Medical ethics, human research
Document type:
Guideline
Institution:
University Health Network (UHN)
Author:
UHN Research Ethics Board (REB)
Target audience:
Healthcare professionals, researchers
Effective period:
Not specified
Approval date:
Not specified
Date of revisions:
Not specified
Note:
Year
Theme:
Research ethics
Document type:
Checklist
Organization / institution:
Research Ethics Board
Target audience:
Principal Investigators
Document Type:
Application form
Purpose:
Determination of exemption from REB review
Reviewing Body:
Research Ethics Board (REB)
Related Policy:
Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS-2)
Scope:
Program evaluation and quality improvement projects involving human participants
Required Information:
Program background, evaluation goals and questions, evaluation plan, consenting process, analysis plan
Ethics Requirements:
TCPS-2 certification status for evaluation team members
Risk Assessment:
Potential risks including confidentiality and privacy considerations
Benefit Assessment:
Potential benefits associated with the evaluation
Data Governance:
Data sharing, ownership, access, retention, and destruction provisions
Legal Considerations:
Legal agreements and third-party user agreements
Privacy and Security:
Privacy safeguards and e-Health/IT security measures
Human Resources:
Staffing requirements and roles in the evaluation
Knowledge Dissemination:
Plans for reporting and dissemination of findings
Application Fields:
Date of application, program name, institution, evaluation team members
Year:
2026
Region / City:
Ottawa, Canada
Topic:
Research Ethics Review
Document Type:
Guidelines
Institution:
Bruyère Health
Author:
Bruyère Health Research Ethics Board
Target Audience:
Researchers conducting studies involving human participants at Bruyère Health
Period of Validity:
Ongoing
Approval Date:
2026
Date of Revisions:
Not specified
Context:
Guidelines for submitting research studies involving human participants to the Bruyère Health Research Ethics Board (REB), detailing review types, necessary forms, and ethical requirements.
Note:
Year
Organization / Institution:
University of Guelph
Target Audience:
Research Personnel
Year:
2016
Region / City:
N/A
Topic:
Clinical Research, Adverse Events Reporting
Document Type:
Guideline
Organization:
William Osler Health System
Author:
N/A
Target Audience:
Researchers, Investigators, REB Members
Effective Period:
N/A
Approval Date:
22 November 2016
Date of Changes:
N/A
Context:
A guideline for reporting unanticipated problems and serious adverse events in clinical research trials.
Organization:
CHEO Research Ethics Board (REB)
Country:
Canada
Document type:
Guidance document
Subject:
Electronic written informed consent in human research
Related policy:
Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS2-2018)
Legal framework:
Canada Evidence Act; Personal Information Protection and Electronic Documents Act (PIPEDA); US Code of Federal Regulations Title 21 Part 11
Applicable sector:
Human research and clinical trials
Target audience:
Researchers and investigators conducting human participant research
Key topics:
electronic consent procedures, digital signatures, participant identity verification, consent documentation, privacy and confidentiality requirements
Special context:
COVID-19 pandemic procedures for remote consent
Research setting:
Clinical trials and health research involving human participants
Document components:
consent procedures, electronic signature requirements, study protocol documentation, email consent attestation template
Year:
2023
Region / City:
Thunder Bay, Ontario
Topic:
Research Ethics Board (REB) Application
Document Type:
Research Ethics Application
Organization / Institution:
Thunder Bay Regional Health Sciences Centre
Author:
Not provided
Target Audience:
Research ethics committee members
Effective Date:
2023
Date of Changes:
N/A
Year:
2024
Organization:
CHEO Research Ethics Board (REB)
Type of Document:
Schedule
Content:
Submission deadlines and corresponding meeting dates
Audience:
Researchers submitting to CHEO REB
Period Covered:
January–December 2024
No Meeting Period:
August 2024
Document Format:
Table
Note:
Year
Contextual Description:
A revision of a consent form template for verbal consent in research studies, outlining the necessary adjustments and additional language to ensure understanding and participation.
Year:
2023
Region / City:
Ottawa, Canada
Subject:
Research Ethics, Medical Consent Forms
Document Type:
Policy Guidelines
Author:
CHEO Research Ethics Board (REB)
Target Audience:
Researchers, Ethics Committees, Medical Practitioners
Validity Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2004
Region / City:
Ontario
Topic:
Research Ethics Board Application
Document Type:
Application Form
Institution:
Humber River Health
Author:
Humber River Health
Target Audience:
Researchers, Institutional Review Board
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Region / City:
European Union / European Economic Area
Topic:
REACH Compliance
Document Type:
Questionnaire
Organization:
Volvo Group
Author:
Volvo Group Purchasing Department
Target Audience:
Volvo Group suppliers
Validity Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2018
Region / City:
CERN
Topic:
Particle accelerator performance, LHC upgrades
Document type:
Technical report
Organization / Institution:
CERN
Authors:
Heiko Damerau, Brennan Goddard, Klaus Hanke, Malika Meddahi, Giovanni Rumolo, Elena Shaposhnikova, Rogelio Tomás Garcia
Target audience:
LIU project team members, accelerator and technology departments, HSE and HL-LHC leaders
Effective period:
2018-2023
Approval date:
2018-06-10
Revision history:
1.0, 2018-06-10
Changes history:
First version released
Document type:
Compliance statement
Regulatory framework:
Regulation (EC) No 1907/2006 (REACH)
Jurisdiction:
European Union
Subject:
Substances of Very High Concern (SVHC)
SVHC list version:
ECHA candidate list updated on 5 November 2025
Applicable articles:
Article 33, Article 67
Referenced court decision:
European Court of Justice decision C-106/14 of 10 September 2015
Products covered:
Specified product parts or model numbers supplied to LINAK
Issuing party:
Supplier company
Authorisation section:
Name, title, date required
Year:
2025
Region / City:
European Union
Topic:
REACH Compliance, SVHC Candidates
Document Type:
Compliance Statement
Organization / Institution:
Tektronix
Author:
Michael Kelly, Product Compliance Manager
Target Audience:
Customers, Environmental Compliance Professionals
Validity Period:
Indefinite
Approval Date:
April 16, 2025
Amendment Date:
Not specified
Year:
2023
Region / city:
Brussels
Subject:
Chemicals, Classification, and Labelling
Document Type:
Meeting Record
Organ / institution:
European Commission
Author:
Directorate-General for Environment, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs
Target audience:
Competent Authorities for REACH and CLP
Period of validity:
06/03/2024
Approval date:
06/03/2024
Date of changes:
N/A
Contextual description:
A record of the 50th meeting of the Competent Authorities for REACH and CLP, discussing updates on the Globally Harmonized System, ongoing work on new hazard classes, and the implementation of GHS revisions.